Skip to main content
. 2017 Nov 29;6(12):e007034. doi: 10.1161/JAHA.117.007034

Figure 4.

Figure 4

Cumulative risks of the combined end point (ischemic and hemorrhagic) for individual non–vitamin K oral anticoagulants.